ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,075Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 1155

$658K Total Retail Price of All Prescriptions

Rank: 12 out of 1155

551 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 551 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 551 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 9,826 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 609 576 1 3
OMEPRAZOLE 517 442 2 5
LEVOTHYROXINE SODIUM 463 402 3 2
LISINOPRIL 347 345 4 1
METOPROLOL SUCCINATE 310 291 5 17
AMLODIPINE BESYLATE 288 281 6 6
METFORMIN HCL 288 259 6 7
FUROSEMIDE 254 223 8 8
GABAPENTIN 238 218 9 15
HYDROCODONE-ACETAMINOPHEN 236 207 S3 10 4
CITALOPRAM HBR 224 206 11 19
METOPROLOL TARTRATE 207 190 12 14
WARFARIN SODIUM 206 200 13 11
ATORVASTATIN CALCIUM 173 153 14 12
POTASSIUM CHLORIDE 165 153 15 16
CRESTOR 136 128 16 34
ATENOLOL 134 122 17 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 106 18 26
HYDROCHLOROTHIAZIDE 121 97 19 9
ADVAIR DISKUS 121 98 19 35
BYSTOLIC 119 111 21 92
GLYBURIDE 119 119 R 21 75
PAROXETINE HCL 117 99 23 48
TRAZODONE HCL 110 99 24 22
LOSARTAN POTASSIUM 107 103 25 18
DIGOXIN 100 96 26 54
NAMENDA 100 90 26 67
CYMBALTA 97 66 28 46
CARVEDILOL 95 81 29 28
SPIRIVA 88 88 30 49
CELEBREX 85 84 31 132
PREDNISONE 82 79 32 40
JANUVIA 79 77 33 127
ALLOPURINOL 78 76 34 29
DONEPEZIL HCL 77 77 35 41
LOSARTAN-HYDROCHLOROTHIAZIDE 75 63 36 65
LANTUS 74 74 37 39
ESTRADIOL 74 55 R 37 60
MIRTAZAPINE 72 72 39 61
RAMIPRIL 69 66 40 125
SPIRONOLACTONE 65 58 41 55
QUETIAPINE FUMARATE 64 54 42 77
OLANZAPINE 64 38 42 120
ALENDRONATE SODIUM 59 59 44 25
ZOLPIDEM TARTRATE 59 46 44 21
FAMOTIDINE 56 51 46 76
RANITIDINE HCL 56 51 46 33
VENTOLIN HFA 54 33 48 84
SERTRALINE HCL 53 53 49 24
DIOVAN HCT 53 53 49 190
DIOVAN 52 52 51 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.